Bristol-Myers Squibb Foundation and Corporate Philanthropy

+12.05.2007 Governor Riley Announces Grant to Improve Mental Health Services in the Black Belt +11.30.2007 Bristol-Myers Squibb Joins with NJ Children's Hospital in Launching New Center for Immune System Disorders and Infectious Diseases Including HIV/AIDS +11.27.2007 World AIDS Day Campaign to Shine a Light of Hope on the HIV/AIDS Epidemic in the United States

Health Disparities

Disparities - or inequalities - in health care occur when certain population groups do not enjoy the same health status as others. They may have less access to health care, to education or prevention programs, or they may be exposed to some social stigma related to their diseases or to their own status. These disparities ultimately may result in a greater incidence of disease and higher mortality rates in some population groups than others. Addressing specific health disparities can directly extend and enhance people's lives.

The Bristol-Myers Squibb Foundation seeks to improve the health outcomes of populations disproportionately affected by HIV, hepatitis, serious mental illness and cancer. Recognizing the critical role of community-based care and support, the Foundation will develop and support partnerships that strengthen and integrate healthcare worker capacity and supportive services at the community level.

HIV/AIDS in Africa -- SECURE THE FUTURE®

Hepatitis in Asia

Cancer in Europe

Serious Mental Illness in the U.S.

Product Donations

[Top Page] [Search] [Index] [Contact] [Home]

Italicized product names are trademarks of Bristol-Myers Squibb Company or one of its divisions or subsidiaries. Abilify is a trademark of Otsuka Pharmaceutical Co., Ltd. Erbitux is a trademark of ImClone Systems Incorporated. EMSAM is a trademark of Somerset Pharmaceuticals, Inc. Glucophage, Glucovance and Metaglip are trademarks of Merck Santé S.A.S., an associate of Merck KGaA of Darmstadt, Germany. Avapro, Avalide and Plavix are trademarks of sanofi-aventis. Sinemet CR is a trademark of Merck & Co., Inc.